Menu
GWAS Study

Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia.

Lin WY, Fordham SE, Sunter N et al.

33510140 PubMed ID
GWAS Study Type
842 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LW
Lin WY
FS
Fordham SE
SN
Sunter N
EC
Elstob C
RT
Rahman T
WE
Willmore E
SC
Shepherd C
SG
Strathdee G
MT
Mainou-Fowler T
PR
Piddock R
MH
Mearns H
BT
Barrow T
HR
Houlston RS
MH
Marr H
WJ
Wallis J
SG
Summerfield G
MS
Marshall S
PA
Pettitt A
PC
Pepper C
FC
Fegan C
FF
Forconi F
DM
Dyer MJS
JS
Jayne S
SA
Sellors A
SA
Schuh A
RP
Robbe P
OD
Oscier D
BJ
Bailey J
RS
Rais S
BA
Bentley A
CL
Cawkwell L
EP
Evans P
HP
Hillmen P
PG
Pratt G
AD
Allsup DJ
AJ
Allan JM
Chapter II

Abstract

Summary of the research findings

Prognostication in patients with chronic lymphocytic leukemia (CLL) is challenging due to heterogeneity in clinical course. We hypothesize that constitutional genetic variation affects disease progression and could aid prognostication. Pooling data from seven studies incorporating 842 cases identifies two genomic locations associated with time from diagnosis to treatment, including 10q26.13 (rs736456, hazard ratio (HR) = 1.78, 95% confidence interval (CI) = 1.47-2.15; P = 2.71 × 10-9) and 6p (rs3778076, HR = 1.99, 95% CI = 1.55-2.55; P = 5.08 × 10-8), which are particularly powerful prognostic markers in patients with early stage CLL otherwise characterized by low-risk features. Expression quantitative trait loci analysis identifies putative functional genes implicated in modulating B-cell receptor or innate immune responses, key pathways in CLL pathogenesis. In this work we identify rs736456 and rs3778076 as prognostic in CLL, demonstrating that disease progression is determined by constitutional genetic variation as well as known somatic drivers.

755 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

842
Total Participants
GWAS
Study Type
Yes
Replicated
87 individuals
Replication Participants
European
Ancestry
U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.